S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
NASDAQ:DCGO

DocGo (DCGO) Stock Price, News & Analysis

$4.06
+0.17 (+4.37%)
(As of 03/27/2024 ET)
Today's Range
$3.86
$4.06
50-Day Range
$3.15
$4.13
52-Week Range
$2.78
$10.82
Volume
498,461 shs
Average Volume
1.29 million shs
Market Capitalization
$422.93 million
P/E Ratio
58.00
Dividend Yield
N/A
Price Target
$11.83

DocGo MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
191.5% Upside
$11.83 Price Target
Short Interest
Bearish
11.46% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.53mentions of DocGo in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$36,100 Bought Last Quarter
Proj. Earnings Growth
47.22%
From $0.36 to $0.53 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.24 out of 5 stars

Medical Sector

164th out of 939 stocks

Health Services Industry

2nd out of 10 stocks

DCGO stock logo

About DocGo Stock (NASDAQ:DCGO)

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

DCGO Stock Price History

DCGO Stock News Headlines

Your $200 account credit is about to expire
Update to MarketBeat All Access and Save $300 on Your Annual Subscription
DocGo Leadership Purchase Shares in Open Market
The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
Expert Outlook: DocGo Through The Eyes Of 4 Analysts
DocGo Inc. (NASDAQ:DCGO) Q4 2023 Earnings Call Transcript
Recap: DocGo Q4 Earnings
DocGo GAAP EPS of $0.06, revenue of $199.2M
DocGo price target lowered by $1 at Stifel, here's why
DCGO Aug 2024 2.000 call
DCGO Aug 2024 3.000 put
DCGO May 2024 3.000 put
DCGO Mar 2024 4.000 put
DCGO Mar 2024 3.000 call
DCGO Mar 2024 2.000 call
See More Headlines
Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/27/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:DCGO
Fax
N/A
Employees
4,164
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.83
High Stock Price Target
$16.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+191.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$6.86 million
Pretax Margin
2.61%

Debt

Sales & Book Value

Annual Sales
$624.29 million
Cash Flow
$0.22 per share
Book Value
$2.93 per share

Miscellaneous

Free Float
89,816,000
Market Cap
$422.93 million
Optionable
Optionable
Beta
0.91
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Stanley Vashovsky (Age 51)
    Co-Founder & Non-Executive Chairman
    Comp: $2.45M
  • Mr. Lee Bienstock (Age 39)
    Chief Executive Officer
    Comp: $1.24M
  • Mr. Ely D. Tendler (Age 56)
    General Counsel, Secretary & Director
  • Mr. Norman Rosenberg (Age 54)
    Treasurer & CFO
  • Mike Cole
    Vice President of Investor Relations
  • Mr. Stephen Sugrue (Age 52)
    Chief Compliance Officer
  • Mr. Ben Sherman
    EVP of Corporate Development
  • Ms. Rosemarie Milano
    Vice President of Human Resources
  • Mr. Andre Oberholzer CPA (Age 66)
    Executive Vice President of Strategy
    Comp: $1.75M
  • Mr. Aaron Severs
    Chief Product Officer

DCGO Stock Analysis - Frequently Asked Questions

Should I buy or sell DocGo stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DCGO shares.
View DCGO analyst ratings
or view top-rated stocks.

What is DocGo's stock price target for 2024?

5 Wall Street research analysts have issued 1 year price objectives for DocGo's shares. Their DCGO share price targets range from $10.00 to $16.00. On average, they expect the company's share price to reach $11.83 in the next year. This suggests a possible upside of 191.5% from the stock's current price.
View analysts price targets for DCGO
or view top-rated stocks among Wall Street analysts.

How have DCGO shares performed in 2024?

DocGo's stock was trading at $5.59 on January 1st, 2024. Since then, DCGO stock has decreased by 27.4% and is now trading at $4.06.
View the best growth stocks for 2024 here
.

When is DocGo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our DCGO earnings forecast
.

How were DocGo's earnings last quarter?

DocGo Inc. (NASDAQ:DCGO) released its quarterly earnings results on Wednesday, February, 28th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.13 by $0.07. The company had revenue of $199.25 million for the quarter, compared to the consensus estimate of $195.48 million. DocGo had a net margin of 1.10% and a trailing twelve-month return on equity of 2.01%.

What ETFs hold DocGo's stock?

ETFs with the largest weight of DocGo (NASDAQ:DCGO) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has DocGo issued on next quarter's earnings?

DocGo updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $720.0 million-$750.0 million, compared to the consensus revenue estimate of $753.9 million.

Who are DocGo's major shareholders?

DocGo's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.62%), Vanguard Group Inc. (4.61%), WCM Investment Management LLC (2.49%), Granahan Investment Management LLC (1.28%), Northern Trust Corp (1.18%) and S Squared Technology LLC (0.99%). Insiders that own company stock include Adriaan Stephanus Oberholzer, Anthony Capone, Ely D Tendler, James M Travers, Lee Bienstock, Michael J Burdiek and Stephen Sugrue.
View institutional ownership trends
.

How do I buy shares of DocGo?

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DCGO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners